Search Results
Search results for "assay development"
Results found for "assay development"
- Bell-Evans model and steered molecular dynamics in uncovering the dissociation kinetics of ligands..
receptors "Recently, academic and industrial scientific communities involved in kinetics-based drug development
- Gαs and Gαq/11 protein coupling bias of two AVPR2 mutants (R68W and V162A) that cause nephrogenic di
conformation of the receptor and consequently activated signaling pathways, and also may shed light on the development
- Trevena Adds Seasoned Biopharma Commercial Executive to Senior Leadership Team
(Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel
- Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR
library for its industry-leading biology platform to identify potential GPCR targets and advance the development
- Effect Delta-9-tetrahydrocannabinol and cannabidiol on milk proteins and lipid levels in HC11 cells
impact of cannabis or its components, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), on MG development
- Addex raises $4.2 million in equity financing
, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development
- California gold rush for Sosei Heptares
The vision is to develop novel muscarinic receptor agonists for schizophrenia and other neuropsychiatric
- Intermolecular Interactions in G Protein-Coupled Receptor Allosteric Sites at the Membrane Interface
Calculations "Allosteric modulators are called promising candidates in G protein-coupled receptor (GPCR) drug development
- GRK2 in cardiovascular disease and its potential as a therapeutic target
Thus, identifying novel molecular targets for developing HF therapeutics remains a key research focus
- Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage ...
translational medicine capabilities • ‘Venture-like’ capital allocation approach to focus pipeline development
- New role of β-arrestins in MOR signaling
severe acute or chronic pain conditions, but their use is overshadowed by their side effects and by the development Morphine is an agonist of Mu opioid receptor (MOPR) and one of the objectives in the development of new
- Increased Anxiety-like Behaviors in Adgra1-/- Male But Not Female Mice are Attributable to...
amygdalae of male mice, implicating a potential, therapeutic application in novel anti-anxiety drug development
- Enhanced membrane binding of oncogenic G protein αqQ209L confers resistance to inhibitor YM-254890
if this loss of PM localization could contribute to the mechanism of inhibition of αqQ209L by YM, we developed
- PH-Binding Motif in PAR4 Oncogene: From Molecular Mechanism to Drug Design
attenuates PAR2&4-Akt/PKB associations; PAR4 instigated Matrigel invasion and migration in vitro and tumor development
- GPR125 (ADGRA3) is an autocleavable adhesion GPCR that traffics with Dlg1 to the basolateral...
These receptors are expressed widely and involved in various functions including development, angiogenesis
- Why Opposing Processes Matter for Your Next GPCR Drug
assumption about how your molecule behaves in a living system can sink months of work and millions in development
- An overview of the compartmentalized GPCR Signaling: Relevance and Implications
specific intracellular compartments and signaling pathways associated with GPCRs holds promise for the development For example, the nuclear envelope presents a barrier that restricts the passage of large molecules, making This may involve the development of specialized delivery vehicles, such as nanoparticles or liposomes
- Biased GPCR signaling by the native parathyroid hormone-related protein 1 to 141 relative to its...
N-terminal fragment 1 to 36 "The parathyroid hormone (PTH)-related protein (PTHrP) is indispensable for the development
- Newly launched antibody libraries put hard-to-drug targets within reach
Antibody developers are increasingly utilising antibody libraries to derive high-quality, drug-like biologics
- Precise druggability of the PTH type 1 receptor
peptide-binding pocket embedded deep within the transmembrane domain limits the identification and development
- TeachOpenCADD - A teaching platform for computer-aided drug design
TeachOpenCADD is a teaching platform developed by students for students, which provides teaching material
- Trevena Announce Submission of New Drug Application in China for OLINVYK® by its Partner Jiangsu ...
royalty on net sales in China CHESTERBROOK, Pa., Jan. 27, 2022 A biopharmaceutical company focused on the development
- 📰 GPCR Weekly News
Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.
- Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
insight not only enhances our understanding of class B1 GPCR biology but also opens new avenues for developing
- 📰 GPCR Weekly News, October 9 to 15, 2023
is essential for meiosis and ascosporogenesis in the wheat scab fungus GPCR Binders, Drugs, and more Development
- Unveiling GPCR Priming: The Hidden Synergy in Cellular Signalling
This has significant implications for drug development, as targeting these non-cognate interactions could
- How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology
Many of the connections that shaped the probes’ development came from simple conversations that began
- 📰 GPCR Weekly News, June 3 to June 9, 2024
Stay informed with the most recent developments in GPCR research and industry news.
- Applications of Cryo-EM in small molecule and biologics drug design
opportunities afforded by emerging technological advances in cryo-EM, and the prospects for future development
- Engineered synaptic tools reveal localized cAMP signaling in synapse assembly
SynTAMs" for synaptic targeting molecules, that enable localized perturbations of cAMP signaling in developing



